EMA — authorised 17 February 2016
- Status: approved
EMA authorised Tagrisso on 17 February 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 17 February 2016.
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.